Longeveron® to Present at the 37th Annual Roth Conference

MIAMI, March 05, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it will participate in the 37^th Annual Roth Conference taking place March 17-18, 2025.

Read more at globenewswire.com